Delivery Order SPE2DB22D3301-SPE2DB24FY1MC
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a potential value of $14,896.40. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is issued under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $1,489.64 and a completion date of March 14, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $2,979.28 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order and has held multiple indefinite delivery contracts (IDCs) with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of RYANODEX 250 MG VIALS. The contract, valued at $2,979.28, has a completion date of February 15, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 250 mg vials of the pharmaceutical product RYANODEX. The contract has a potential value of $7,448.20 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp also...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of RYANODEX 250 MG VIALS, with a potential value of $2,979.28. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support U.S. government agencies, primarily the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.88, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The order is for 4,565,338,781 units of the pharmaceutical product RYANODEX 250 MG VIALS, with a ceiling value of $2,979.28. The contract is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award, valued at $3,210.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product. The contract has a completion date of March 26, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1MCDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $29,792.80 and a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization based in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.8k | 2/27/24 |